DAY 2 OF SUMMER HOLIDAYS
The debate about whether ageing is a natural or physiological process is not trivial. For Pharma to develop drugs to treat ageing they need it to be classed as a disease. Why? Money
Third party payers only pay for treatments and the management of diseases and not for lifestyle issues. Is this important for MS? If a component of progressive MS is premature ageing then we want ageing to be a disease. This will create the incentives for drug development. Do you agree?